alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

118TH CONGRESS 

2D SESSION H. R. 7652 

To increase oversight and transparency with respect to Medicare billing codes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 13, 2024 

Mr. CISCOMANI (for himself, Mr. DAVIS of North Carolina, Mrs. 

HARSHBARGER, and Mr. HUIZENGA) introduced the following bill; which 

was referred to the Committee on Ways and Means, and in addition to 

the Committee on Energy and Commerce, for a period to be subsequently 

determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To increase oversight and transparency with respect to 

Medicare billing codes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Oversight of Medicare 

5 Billing Code Cost Act’’. 

6 SEC. 2. INCREASING OVERSIGHT AND TRANSPARENCY 

7 WITH RESPECT TO MEDICARE BILLING 

8 CODES. 

9 (a) HHS OIG STUDY AND REPORT.— 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7652 IH

1 (1) STUDY.—The Inspector General of the De2 partment of Health and Human Services shall con3 duct a comprehensive study of the processes used by 

4 the Centers for Medicare & Medicaid Services for 

5 adding, modifying, and removing billing codes under 

6 the Medicare program under title XVIII of the So7 cial Security Act (42 U.S.C. 1395 et seq.). Such 

8 study shall include an analysis of— 

9 (A) the level and types of data and anal10 ysis considered; 

11 (B) trends in the number and types of 

12 codes added, modified, removed, or revalued; 

13 (C) areas or specialties with the highest 

14 growth; and 

15 (D) efforts by the Centers for Medicare & 

16 Medicaid Services to monitor effects on out17 comes, costs over time, and other issues. 

18 (2) REPORT.—Not later than 12 months after 

19 the date of enactment of this Act, the Inspector 

20 General shall submit to Congress a report containing 

21 the results of the study conducted under paragraph 

22 (1), together with recommendations for such legisla23 tion and administrative action the Inspector General 

24 determines appropriate to improve transparency and 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7652 IH

1 oversight of the processes described in such para2 graph. 

3 (b) ANNUAL REPORTING ON NEW MEDICARE BILL4 ING CODES.—Not later than June 1 of each year (begin5 ning with 2024), the Secretary of Health and Human 

6 Services shall submit to Congress and make publicly avail7 able on the internet website of the Centers for Medicare 

8 & Medicaid Services a report listing any billing codes 

9 added under the Medicare program under title XVIII of 

10 the Social Security Act during the preceding year, along 

11 with the associated volume and expenditures for such 

12 codes under the Medicare program. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
# APPENDIX O

# Flight Checklist

LED
Motors inactive, safe to handle Low battery, automatic landing Loss of RC signal, automatic landing Pre-arm safety check failure Loss of GPS signal, switch to manual Initializing, hold the X8 level Acquiring GPS, please wait Autopilot ready, GPS locked Armed 

## Safety Button Motors active, deactivate before handling (see reverse) 

## Flight Modes Return to launch **RTL** land at the launch point Stabalize Altitude Hold Loiter Full Autonomy Return to Launch 

### Standard position (altitude hold mode) **STD** fly manually Stabalize Altitude Hold Loiter Full Autonomy Return to Launch



### Loiter mode **LTR** hover Stabalize Altitude Hold Loiter Full Autonomy Return to Launch 

# ! Stand back! 

# 4 6 The motors are now active. Hold left stick down right until motors spin. 

# 2 1 Power on controller; set to STD and RTL OFF.
Arm motors. Press and hold safety button until solid red. Connect charged battery.

Choose a clear launch point, and face the X8 away from you. 

# 5 Check LED. 

# 3 Place the X8 at launch point. Go outside to an open area! See the Operation Manual for complete instructions.



### Auto mode **AUTO** fly a mission Stabalize Altitude Hold Loiter Full Autonomy Return to Launch ©2014 3D Robotics. vB. DCT0005 All rights reserved. 

### Control gimbal **TILT** tilt the camera down and up 

### Land **CH7** land at the current position Stabalize Altitude Hold Loiter Full Autonomy Return to Launch Stabalize Altitude Hold Loiter Full Autonomy Return to Launch

Stabalize Altitude Hold Loiter Full Autonomy Return to Launch 

# X8 + Hold the X8 still and level while powering on.Press and hold until blinking red to deactivate.Hold left stick downleft until motors stop. 

# 1 2 Disarm motors. Press safety button. 

# 3 Disconnect battery. 

# 4 Power off controller. 

## Postflight Controller Flight Data Press and hold the DN button to access the flight data screens. Press DN again to toggle between screens.

Lower left stick below center to descend. Set left stick fully down to land when near the ground. Left Stick
Left Stick Raise left stick above center to take off and gain altitude. Move left stick left and right to rotate. Use right stick to fly forward, backward, left, and right. Set left stick to center to maintain altitude. Left Stick Left Stick 

## Flight current flight mode
controller battery level (9-12 V) GPS signal strength in # of satellites meters from launch point flight battery level (14-16.8 V) connection strength
current latitude current longitude altitude in meters flight time altitude in meters



### For customer support, contact us at help@3dr.com or call our support line at +1 (858) 225-1414 Monday through Friday, from 8 am to 5 pm, PST. 3DR.com/X8/info GPS status speed in m/s flight battery mAh consumed since armed **End your flight at 14.1 V.** Do not exceed 8,000 mAh for a fully charged X8 + battery (80% of available capacity). 

# !
<PAGE>   1

                                                                      EXHIBIT 13
                                                                      ----------

INDEPENDENT PUBLIC ACCOUNTANTS' REVIEW REPORT


To the Board of Directors and Shareholders of
Essef Corporation
Chardon, Ohio


We have reviewed the accompanying condensed consolidated balance sheet of Essef
Corporation and Subsidiaries (the "Company") as of March 31, 1999, and the
related condensed consolidated statements of income for the three month and six
month periods ended March 31, 1999 and 1998, and their cash flows for the
six-month periods ended March 31, 1999 and 1998. These financial statements are
the responsibility of the Company's management.

We conducted our reviews in accordance with standards established by the
American Institute of Certified Public Accountants. A review of interim
financial information consists principally of applying analytical procedures to
financial data and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit conducted in
accordance with generally accepted auditing standards, the objective of which is
the expression of an opinion regarding the financial statements taken as a
whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to such condensed consolidated financial statements for them to be in
conformity with generally accepted accounting principles.

We have previously audited, in accordance with generally accepted auditing
standards, the consolidated balance sheet of the Company as of September 30,
1998, and the related consolidated statements of income, shareholders' equity,
and cash flows for the year then ended (not presented herein) and in our report
dated November 13, 1998, we expressed an unqualified opinion on those
consolidated financial statements. In our opinion, the information set forth in
the accompanying condensed consolidated balance sheet as of September 30, 1998
is fairly stated, in all material respects, in relation to the consolidated
balance sheet from which it has been derived.


DELOITTE & TOUCHE LLP

Cleveland, Ohio
April 20, 1999



                                  Page 17 of 18
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       9,386,069
<SECURITIES>                                35,243,624
<RECEIVABLES>                                4,426,351
<ALLOWANCES>                                 (650,000)
<INVENTORY>                                    103,030
<CURRENT-ASSETS>                               575,597
<PP&E>                                       5,309,365
<DEPRECIATION>                             (2,105,434)
<TOTAL-ASSETS>                              53,487,175
<CURRENT-LIABILITIES>                        7,353,822
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       103,438
<OTHER-SE>                                  45,979,762
<TOTAL-LIABILITY-AND-EQUITY>                53,487,175
<SALES>                                     17,171,434
<TOTAL-REVENUES>                            17,171,434
<CGS>                                        7,680,856
<TOTAL-COSTS>                                7,680,856
<OTHER-EXPENSES>                            24,195,638
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                           (12,817,132)
<INCOME-TAX>                                    19,000
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (12,836,132)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                   (1.37)


</TABLE>
EXHIBIT 31.2

CERTIFICATION

SECTION 302 CERTIFICATION OF OUR CHIEF FINANCIAL OFFICER

I, Joseph C Sienkiewicz, certify that:



1.    I have reviewed this annual report on Form 10-KSB of Smart-tek Solutions, Inc.;



2.

Based on my knowledge, this report does not contain any untrue statement of

material fact or omit to state a material fact necessary to make the statements

made, in light of the circumstances under which such statements were made,

not misleading with respect to the period covered by this report;



3.    Based on my knowledge, the financial statements, and other financial

information included in this report, fairly present in all material

respects the financial condition, results of operations and cash flows of

the registrant as of, and for, the periods presented in this report;



4.    The registrant's other certifying officer and I are responsible for

establishing and maintaining disclosure controls and procedures (as

defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant

and have:



(a)   Designed such disclosure controls and procedures, or caused such

disclosure controls and procedures to be designed under our

supervision, to ensure that material information relating to the

registrant, including its consolidated subsidiaries, is made known

to us by others within those entities, particularly during the

period in which this report is being prepared;



(b)   Evaluated the effectiveness of the registrant's disclosure controls

and procedures and presented in this report our conclusions about

the effectiveness of the disclosure controls and procedures, as of

the end of the period covered by this report based on such

evaluation; and



(c)   Disclosed in this report any change in the registrant's internal

control over financial reporting that occurred during the

registrant's most recent fiscal quarter (the registrant's fourth

quarter in the case of an annual report) that has materially

affected, or is reasonably likely to materially affect, the

registrant's internal control over financial reporting; and



5.    The registrant's other certifying officer and I have disclosed, based on

our most recent evaluation of internal control over financial reporting,

to the registrant's auditors and the audit committee of the registrant's

board of directors (or persons performing the equivalent functions):



(a)   All significant deficiencies and material weaknesses in the design

or operation of internal control over financial reporting which are

reasonably likely to adversely affect the registrant's ability to

record, process, summarize and report financial information; and



(b)   Any fraud, whether or not material, that involves management or

other employees who have a significant role in the registrant's

internal control over financial reporting.



/s/ Joseph C Sienkiewicz

------------------------------

Joseph C Sienkiewicz

Chief Financial Officer



October xx, 2005
<PAGE>

                                                                   EXHIBIT 10.20

                                    AGREEMENT

This Agreement is made this 21 day of October, 1999, by and between Mackie
Designs Inc. ("Mackie"), a Washington corporation, and Jamie Engen ("Engen").

                                    RECITALS

A. Engen is the Chief Operating Officer of Mackie, having moved to Seattle from
Vancouver, British Columbia to assume this position.

B. Mackie wishes to defray certain expenses incurred by Engen in such move and
to assist Engen in relocating his family from Vancouver to the Woodinville,
Washington area.

Based upon the above recitals, the parties promise and agree as follows:

1. COST REIMBURSEMENT: Engen has incurred out-of-pocket expenses with respect to
the sale of his home in Vancouver totaling US$52,925. Mackie shall reimburse
Engen for such costs upon execution and delivery of this Agreement.

2. LOAN: Mackie hereby loans the sum of $250,000 to Engen upon the following
terms and conditions:

         2.1 Subject to the provisions of Section 2.4, the principal amount of
         the loan shall become due and payable in full on or before October 31,
         2004, or upon the termination of Engen's employment with Mackie,
         whichever shall first occur;

         2.2 The loan shall bear no interest; and,

         2.3 The loan shall be secured by a deed of trust in a form satisfactory
         to Mackie upon any residence purchased by Engen in the United States,
         which deed of trust shall be not less than second in priority as to all
         other encumbrances upon the residence.

3. WASHINGTON LAW: This Agreement shall be construed under the laws of the State
of Washington.

4. BINDING EFFECT: This Agreement shall inure to the benefit of, and be binding
upon, the parties hereto and their respective successors, personal
representatives, heirs and/or assigns.

5. ATTORNEY'S FEES: In the event of any litigation arising out of this Agreement
or any claimed breach thereof, the prevailing party in such litigation shall be
entitled to


                                                                        PAGE - 1
<PAGE>


recover his or its reasonable attorney's fees and reasonable costs of litigation
(including on appeal thereof), in addition to any other award or decree granted
or given by the court.

6. TIME: Time is of the essence of this Agreement.

MACKIE DESIGNS INC.

By:  /s/ Buck Ferguson                  /s/ Jamie Engen
     --------------------------         --------------------------
      Title:  Director                  Jamie Engen


                                                                        PAGE - 2
SAT Report

PMN Number: P-13-0951

SAT Date: 11/1/2013

Print Date: 8/4/2014

Related cases:

Concern levels:

Type of Concern: Health Eco Comments

Level of Concern: 1 3

 Persistence Bioaccum Toxicity Comments

3 11

Exposure Based Review:

Health: No

Ecotox: Yes

Routes of exposure: Health: No exposures needed

Ecotox: All releases to water

Fate: ;

Keywords:

 Keywords: 

Summary of Assessment:

 Fate:

Fate Summary: P-13-0951

FATE: 

Solid 

S < 0.001 mg/L at 25 C (E)

VP < 1.0E-6 torr at 25 C (E)

BP > 400 C (E)

H < 1.00E-8 (E)

POTW removal (%) = 90 via sorption

Time for complete ultimate aerobic biodeg > mo

Sorption to soils/sediments = strong
PBT Potential: P3B1

*CEB FATE: Migration to ground water = slow

 Health:

 Health Summary: Absorption is nil all routes (pchem). No significant 

health concerns.

 Ecotox:

Test Organism Test 

Type

Test End 

Point

Predicted Measured Comments

fish 96-h LC50 28.3

daphnid 48-h LC50 3

green algal 96-h EC50 0.152

fish _ chronic value 1.5

daphnid _ chronic 

value

0.237

algal _ chronic 

value

0.03

Sewage Sludge 3-h EC50 _

Sewage Sludge _ Chronic 

Value

_

Ecotox Values Comments: Predictions are based on SAR-nearest analog analysis for soluble 

Zn; SAR chemical class = soluble zinc; MW1320 with Zn; liquid; S < 0.001 mg/L at 

20 C (P); pH7; effective concentrations based on 100% active ingredients and mean measured 

concentrations of total Zn; hardness < 150.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments

Assessment Factor 10

Concentration of Concern 

(ppb)

3

SARs soluble zinc

SAR Class soluble zinc

Ecotox Category Soluble complexes of Zinc

Ecotox Factors Comments: 

 SAT Chair: L Keifer 564-8916
PETITION FOR EXEMPTION/RULEMAKING

IN THE MATTER OF THE PETITION FOR EXEMPTION OF: Frank G. Harris LLC FOR AN EXEMPTION SEEKING RELIEF FROM THE REQUIREMENTS OF TITLE 14 OF THE CODE OF FEDERAL REGULATIONS SECTIONS 61.113(a) & (b), 91.7(a), 91.121, 91.151(b ), 91.405(a), 91.407(a)(1), 91.409(a)(1) & (a)(2), AND 91.417(a) & (b) CONCERNING COMMERCIAL OPERATION OF DJI PHANTOM 3 UNMANNED AIRCRAFT SYSTEMS PURSUANT TO SECTION 333 OF THE FAA MODERNIZATION AND REFORM ACT OF 2012 (PUBLIC LA

W 112

- 95) Frank Harris 7110 51 st Place East Bradenton, Florida 34203 Telephone: 941.962.3177 frank@lwrhome.com
CHARLES EARL JOHNSON JR.

,

Appellant,

v.

STATE OF FLORIDA

,

Appellee

. IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 17

- 1112

_____________________________/

Opinion filed July 12, 201 7.

An appeal from the Circuit Court for Escambia County

. Jan Shackelford , Judge

.

Andy Thomas, Public Defender, and Steven L. Seliger, Assistant Public Defender,

Tallahassee , for Appellant.

Pamel a Jo Bondi, Attorney General, Tallahassee , for Appellee.

PER CURIAM.

AFFIRMED.

LEWIS, WETHERELL, and WINSOR, JJ., CONCUR.
# C_2017144EN.01006102.xml

| 8.5.2017 | EN | Official Journal of the European Union | C 144/61 |
| --- | --- | --- | --- |

8.5.2017

EN

Official Journal of the European Union

C 144/61

---

Order of the General Court of 9 March 2017 — MIP Metro v EUIPO — Associated Newspapers (METRO)

(Case T-697/14) (1)

1

(2017/C 144/87)

Language of the case: German

The President of the Sixth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 409, 17.11.2014.

1

---
```

[Federal Register Volume 77, Number 211 (Wednesday, October 31, 2012)]
[Notices]
[Page 65892]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26597]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality

Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10 (a)(2) of the Federal Advisory 
Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for 
Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP) 
meeting on ``AHRQ NATIONAL RESEARCH SERVICE AWARDS (NRSA) INSTITUTIONAL 
RESEARCH TRAINING GRANTS (T32)''.

DATES: November 14-15, 2012 (Open on November 14 from 8:00 a.m. to 8:30 
a.m. and closed for the remainder of the meeting).

ADDRESSES: Gaithersburg Marriott, RIO, 9751 Washingtonian Boulevard, 
Gaithersburg, MD 20878.

FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of 
members, agenda or minutes of the non-confidential portions of this 
meeting should contact: Mrs. Bonnie Campbell, Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 
20850, Telephone: (301) 427-1554.
    Agenda items for this meeting are subject to change as priorities 
dictate.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
the Agency for Healthcare Research and Quality (AHRQ), and agree to be 
available, to conduct on an as needed basis, scientific reviews of 
applications for AHRQ support.
    Individual members of the Panel do not attend regularly-scheduled 
meetings and do not serve for fixed terms or a long period of time. 
Rather, they are asked to participate in particular review meetings 
which require their type of expertise.
    Substantial segments of the SEP meeting referenced above will be 
closed to the public in accordance with the provisions set forth in 5 
U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 
552b(c)(6). Grant applications for ``AHRQ NATIONAL RESEARCH SERVICE 
AWARDS (NRSA) INSTITUTIONAL RESEARCH TRAINING GRANTS (T32)'' are to be 
reviewed and discussed at this meeting. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Dated: October 12, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-26597 Filed 10-30-12; 8:45 am]
BILLING CODE 4160-90-M
```
### Michigan Supreme Court Lansing, Michigan

Marilyn Kelly,
Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk September 11, 2009

s0831 

# Order

September 11, 2009

138760

DARCY LYNN DEAN, Plaintiff-Appellee,

v SC: 138760 COA: 288889 Kent CC: 97-012933-DC GARY MICHAEL HENNING, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application fo r leave to appeal the March 19, 2009 order of the Court of Appeals is considered, and it is DENIED, because we are not persuaded that the question presented should be reviewed by this Court.